{"id":163798,"date":"2026-07-22T13:12:27","date_gmt":"2026-07-22T07:42:27","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=163798"},"modified":"2026-07-22T13:12:28","modified_gmt":"2026-07-22T07:42:28","slug":"complex-generics-api-pharma-manufacturing-stocks-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/complex-generics-api-pharma-manufacturing-stocks-2026\/","title":{"rendered":"3 Complex Generics and API Pharma Manufacturing Stocks"},"content":{"rendered":"<div class=\"meta-block\"><\/div>\n<p style=\"border-left: 4px solid #1F4E79; background: #EBF3FB; padding: 10px 16px; font-style: italic;\"><em>Granules India, Natco Pharma and Aurobindo Pharma continue expanding complex generics and API pharmaceutical manufacturing capacity for global markets.<\/em><\/p>\n<p>Granules India, Natco Pharma and Aurobindo Pharma are among the complex generics and API pharma manufacturing stocks, each positioned within India&#8217;s complex generics and API pharmaceutical manufacturing growth story through distinct business drivers.<\/p>\n<p>India&#8217;s complex generics and API pharmaceutical manufacturing sector continues to see sustained investment and demand growth, and complex generics and API pharma manufacturing stocks reflects companies with the clearest exposure to this trend.<\/p>\n<p style=\"margin-top: 24px;\"><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&amp;utm_medium=complex-generics-api-pharma-manufacturing-stocks\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/a><\/p>\n<p>This article examines Granules India, Natco Pharma and Aurobindo Pharma as complex generics and API pharma manufacturing stocks, covering their specific growth drivers and the risks of this theme.<\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/complex-generics-api-pharma-manufacturing-stocks-2026\/#What_Defines_the_3_Complex_Generics_and_API_Pharma_Manufacturing_Stocks\" title=\"What Defines the 3 Complex Generics and API Pharma Manufacturing Stocks\">What Defines the 3 Complex Generics and API Pharma Manufacturing Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/complex-generics-api-pharma-manufacturing-stocks-2026\/#Why_These_Are_the_3_Complex_Generics_and_API_Pharma_Manufacturing_Stocks\" title=\"Why These Are the 3 Complex Generics and API Pharma Manufacturing Stocks\">Why These Are the 3 Complex Generics and API Pharma Manufacturing Stocks<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/complex-generics-api-pharma-manufacturing-stocks-2026\/#Granules_India_Vertically_integrated_api_and_finished_dosage_manufacturer\" title=\"Granules India: Vertically integrated api and finished dosage manufacturer\">Granules India: Vertically integrated api and finished dosage manufacturer<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/complex-generics-api-pharma-manufacturing-stocks-2026\/#Natco_Pharma_Complex_generics_specialisation_with_first-to-file_opportunities\" title=\"Natco Pharma: Complex generics specialisation with first-to-file opportunities\">Natco Pharma: Complex generics specialisation with first-to-file opportunities<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/complex-generics-api-pharma-manufacturing-stocks-2026\/#Aurobindo_Pharma_Diversified_generics_and_api_manufacturer_with_substantial_export_revenue\" title=\"Aurobindo Pharma: Diversified generics and api manufacturer with substantial export revenue\">Aurobindo Pharma: Diversified generics and api manufacturer with substantial export revenue<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/complex-generics-api-pharma-manufacturing-stocks-2026\/#Factors_Affecting_the_3_Complex_Generics_and_API_Pharma_Manufacturing_Stocks\" title=\"Factors Affecting the 3 Complex Generics and API Pharma Manufacturing Stocks\">Factors Affecting the 3 Complex Generics and API Pharma Manufacturing Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/complex-generics-api-pharma-manufacturing-stocks-2026\/#Benefits_of_the_3_Complex_Generics_and_API_Pharma_Manufacturing_Stocks\" title=\"Benefits of the 3 Complex Generics and API Pharma Manufacturing Stocks\">Benefits of the 3 Complex Generics and API Pharma Manufacturing Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/complex-generics-api-pharma-manufacturing-stocks-2026\/#Risks_of_the_3_Complex_Generics_and_API_Pharma_Manufacturing_Stocks\" title=\"Risks of the 3 Complex Generics and API Pharma Manufacturing Stocks\">Risks of the 3 Complex Generics and API Pharma Manufacturing Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/complex-generics-api-pharma-manufacturing-stocks-2026\/#How_to_Evaluate_the_3_Complex_Generics_and_API_Pharma_Manufacturing_Stocks\" title=\"How to Evaluate the 3 Complex Generics and API Pharma Manufacturing Stocks\">How to Evaluate the 3 Complex Generics and API Pharma Manufacturing Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/complex-generics-api-pharma-manufacturing-stocks-2026\/#How_to_Invest_in_the_3_Complex_Generics_and_API_Pharma_Manufacturing_Stocks\" title=\"How to Invest in the 3 Complex Generics and API Pharma Manufacturing Stocks\">How to Invest in the 3 Complex Generics and API Pharma Manufacturing Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/complex-generics-api-pharma-manufacturing-stocks-2026\/#Conclusion\" title=\"Conclusion\">Conclusion<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/complex-generics-api-pharma-manufacturing-stocks-2026\/#FAQs\" title=\"FAQs\">FAQs<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/complex-generics-api-pharma-manufacturing-stocks-2026\/#3_Complex_Generics_and_API_Pharma_Manufacturing_Stocks\" title=\"3 Complex Generics and API Pharma Manufacturing Stocks?\">3 Complex Generics and API Pharma Manufacturing Stocks?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/complex-generics-api-pharma-manufacturing-stocks-2026\/#What_drives_Granules_Indias_growth_in_this_theme\" title=\"What drives Granules India&#8217;s growth in this theme?\">What drives Granules India&#8217;s growth in this theme?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/complex-generics-api-pharma-manufacturing-stocks-2026\/#What_drives_Natco_Pharmas_growth_in_this_theme\" title=\"What drives Natco Pharma&#8217;s growth in this theme?\">What drives Natco Pharma&#8217;s growth in this theme?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/complex-generics-api-pharma-manufacturing-stocks-2026\/#What_drives_Aurobindo_Pharmas_growth_in_this_theme\" title=\"What drives Aurobindo Pharma&#8217;s growth in this theme?\">What drives Aurobindo Pharma&#8217;s growth in this theme?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/complex-generics-api-pharma-manufacturing-stocks-2026\/#Is_this_theme_purely_cyclical_or_structural\" title=\"Is this theme purely cyclical or structural?\">Is this theme purely cyclical or structural?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/complex-generics-api-pharma-manufacturing-stocks-2026\/#What_risks_apply_to_the_3_Complex_Generics_and_API_Pharma_Manufacturing_Stocks\" title=\"What risks apply to the 3 Complex Generics and API Pharma Manufacturing Stocks?\">What risks apply to the 3 Complex Generics and API Pharma Manufacturing Stocks?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"What_Defines_the_3_Complex_Generics_and_API_Pharma_Manufacturing_Stocks\"><\/span><strong>What Defines the 3 Complex Generics and API Pharma Manufacturing Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The complex generics and API pharma manufacturing stocks are companies with direct exposure to complex generics and API pharmaceutical manufacturing, combining relevant scale with disclosed growth or expansion plans.<\/p>\n<p>Understanding these complex generics and API pharma manufacturing stocks helps investors identify names positioned to benefit from sustained sector-wide demand rather than one-off catalysts.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_These_Are_the_3_Complex_Generics_and_API_Pharma_Manufacturing_Stocks\"><\/span><strong>Why These Are the 3 Complex Generics and API Pharma Manufacturing Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Granules India&#8217;s vertically integrated API and finished dosage manufacturer, Natco Pharma&#8217;s complex generics specialisation with first-to-file opportunities and Aurobindo Pharma&#8217;s diversified generics and API manufacturer with substantial export revenue together explain why these represent the complex generics and API pharma manufacturing stocks.<\/p>\n<ul>\n<li><strong>Granules India&#8217;s vertically integrated API and finished dosage manufacturer:<\/strong> Granules India&#8217;s its vertically integrated manufacturing model, spanning active pharmaceutical ingredient production through to finished dosage formulations.<\/li>\n<li><strong>Natco Pharma&#8217;s complex generics specialisation with first-to-file opportunities:<\/strong> Natco Pharma&#8217;s its complex generics specialisation, pursuing first-to-file opportunities for harder-to-replicate drug formulations in regulated markets.<\/li>\n<li><strong>Aurobindo Pharma&#8217;s diversified generics and API manufacturer with substantial export revenue:<\/strong> Aurobindo Pharma&#8217;s its diversified generics and API manufacturing business, maintaining substantial export revenue across US and European regulated markets.<\/li>\n<li><strong>Sustained sector-wide demand:<\/strong> Broader structural demand growth across complex generics and API pharmaceutical manufacturing supports all three companies within this theme.<\/li>\n<\/ul>\n<table border=\"1\" cellspacing=\"0\" cellpadding=\"6\">\n<tbody>\n<tr>\n<th>Company<\/th>\n<th>CMP (Rs)<\/th>\n<th>Growth Driver<\/th>\n<th>Sector<\/th>\n<\/tr>\n<tr>\n<td><a href=\"https:\/\/univest.in\/user\/stocks\/granules\/granules-india-ltd-share-price-today\">Granules India<\/a><\/td>\n<td>&#8211;<\/td>\n<td>Vertically integrated api and finished dosage manufacturer<\/td>\n<td>Complex<\/td>\n<\/tr>\n<tr>\n<td><a href=\"https:\/\/univest.in\/user\/stocks\/natcopharm\/natco-pharma-ltd-share-price-today\">Natco Pharma<\/a><\/td>\n<td>&#8211;<\/td>\n<td>Complex generics specialisation with first-to-file opportunities<\/td>\n<td>Complex<\/td>\n<\/tr>\n<tr>\n<td><a href=\"https:\/\/univest.in\/user\/stocks\/auropharma\/aurobindo-pharma-ltd-share-price-today\">Aurobindo Pharma<\/a><\/td>\n<td>&#8211;<\/td>\n<td>Diversified generics and api manufacturer with substantial export revenue<\/td>\n<td>Complex<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h3><span class=\"ez-toc-section\" id=\"Granules_India_Vertically_integrated_api_and_finished_dosage_manufacturer\"><\/span><strong>Granules India: Vertically integrated api and finished dosage manufacturer<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Granules India is among the complex generics and API pharma manufacturing stocks, its vertically integrated manufacturing model, spanning active pharmaceutical ingredient production through to finished dosage formulations.<\/p>\n<p>Granules India&#8217;s vertical integration provides cost control and supply chain reliability across its manufacturing process.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Natco_Pharma_Complex_generics_specialisation_with_first-to-file_opportunities\"><\/span><strong>Natco Pharma: Complex generics specialisation with first-to-file opportunities<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Natco Pharma is among the complex generics and API pharma manufacturing stocks, its complex generics specialisation, pursuing first-to-file opportunities for harder-to-replicate drug formulations in regulated markets.<\/p>\n<p>Natco Pharma&#8217;s complex generics focus can generate outsized returns on successful first-to-file launches within specific drug categories.<\/p>\n<p style=\"margin-top: 24px;\"><a href=\"https:\/\/univest.in\/sebi-registered-investment-advisor-india\"><strong>Get SEBI-Registered Research on Complex Generics API Growth Stocks<\/strong><\/a><\/p>\n<h3><span class=\"ez-toc-section\" id=\"Aurobindo_Pharma_Diversified_generics_and_api_manufacturer_with_substantial_export_revenue\"><\/span><strong>Aurobindo Pharma: Diversified generics and api manufacturer with substantial export revenue<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Aurobindo Pharma is among the complex generics and API pharma manufacturing stocks, its diversified generics and API manufacturing business, maintaining substantial export revenue across US and European regulated markets.<\/p>\n<p>Aurobindo Pharma&#8217;s manufacturing scale and regulatory compliance track record support sustained global pharmaceutical export demand.<\/p>\n<p style=\"margin-top: 24px;\"><em>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&amp;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track Granules India, Natco Pharma and Aurobindo Pharma live prices.<\/em><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Factors_Affecting_the_3_Complex_Generics_and_API_Pharma_Manufacturing_Stocks\"><\/span><strong>Factors Affecting the 3 Complex Generics and API Pharma Manufacturing Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li><strong>Execution track record:<\/strong> For the complex generics and API pharma manufacturing stocks, execution against disclosed plans remains the key determinant of realised growth.<\/li>\n<li><strong>Sector-wide demand trends:<\/strong> Broader demand trends across complex generics and API pharmaceutical manufacturing affect all three companies collectively.<\/li>\n<li><strong>Competitive intensity:<\/strong> Rising competition within complex generics and API pharmaceutical manufacturing could pressure margins even amid volume growth.<\/li>\n<li><strong>Input cost and supply chain factors:<\/strong> Cost and supply chain dynamics affect profitability for companies within this theme.<\/li>\n<li><strong>Policy and regulatory support:<\/strong> Government policy support toward complex generics and API pharmaceutical manufacturing affects the sustainability of this growth theme.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"Benefits_of_the_3_Complex_Generics_and_API_Pharma_Manufacturing_Stocks\"><\/span><strong>Benefits of the 3 Complex Generics and API Pharma Manufacturing Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li><strong>Structural growth theme exposure:<\/strong> The complex generics and API pharma manufacturing stocks provide exposure to a sustained, structural growth theme rather than a short-term cycle.<\/li>\n<li><strong>Diversified company selection:<\/strong> Spanning three companies, this list reduces single-stock concentration risk within the theme.<\/li>\n<li><strong>Established execution capability:<\/strong> These companies bring existing scale and expertise to capture growth within complex generics and API pharmaceutical manufacturing.<\/li>\n<li><strong>Policy-aligned positioning:<\/strong> These stocks align with broader government policy priorities supporting this sector.<\/li>\n<li><strong>Multiple growth vectors:<\/strong> Different business models across these three names offer diversified ways to capture the same broad theme.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"Risks_of_the_3_Complex_Generics_and_API_Pharma_Manufacturing_Stocks\"><\/span><strong>Risks of the 3 Complex Generics and API Pharma Manufacturing Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li><strong>Execution risk:<\/strong> These companies still need to execute disclosed plans successfully to realise growth.<\/li>\n<li><strong>Valuation considerations:<\/strong> Strong recent sector performance means current valuations may already reflect growth expectations for the complex generics and API pharma manufacturing stocks.<\/li>\n<li><strong>Competitive pressure:<\/strong> Rising competition within complex generics and API pharmaceutical manufacturing could affect market share and margins over time.<\/li>\n<li><strong>Cyclicality risk:<\/strong> Demand within complex generics and API pharmaceutical manufacturing could prove more cyclical than currently anticipated.<\/li>\n<li><strong>Broader market sentiment risk:<\/strong> Overall market conditions can affect these stocks regardless of company-specific fundamentals.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"How_to_Evaluate_the_3_Complex_Generics_and_API_Pharma_Manufacturing_Stocks\"><\/span><strong>How to Evaluate the 3 Complex Generics and API Pharma Manufacturing Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ol>\n<li>Among the complex generics and API pharma manufacturing stocks, compare execution track record against disclosed growth and expansion plans.<\/li>\n<li>For the complex generics and API pharma manufacturing stocks, assess competitive positioning within the broader complex generics and API pharmaceutical manufacturing sector.<\/li>\n<li>Track quarterly results to confirm continued execution progress.<\/li>\n<li>Consider valuation relative to growth visibility for each name.<\/li>\n<li>Combine sector-theme analysis with standard fundamental research.<\/li>\n<\/ol>\n<h2><span class=\"ez-toc-section\" id=\"How_to_Invest_in_the_3_Complex_Generics_and_API_Pharma_Manufacturing_Stocks\"><\/span><strong>How to Invest in the 3 Complex Generics and API Pharma Manufacturing Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ol>\n<li>Use the Univest platform to track quarterly results and expansion progress for the complex generics and API pharma manufacturing stocks.<\/li>\n<li>Open a demat and trading account with Univest for zero-brokerage execution.<\/li>\n<li>Track quarterly results for Granules India, Natco Pharma and Aurobindo Pharma through the Univest app.<\/li>\n<li>Consult a SEBI-registered advisor before allocating capital to this theme.<\/li>\n<li>Review positions periodically as execution progress and sector trends evolve.<\/li>\n<\/ol>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><strong>Conclusion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Granules India, Natco Pharma and Aurobindo Pharma represent the complex generics and API pharma manufacturing stocks, each capturing different aspects of India&#8217;s sustained complex generics and API pharmaceutical manufacturing growth story. Historically, this structural theme has offered diversified exposure across multiple companies, though execution risk and valuation considerations remain important factors. Consult a SEBI-registered advisor before making investment decisions.<\/p>\n<div style=\"background: #CC0000; border-radius: 8px; padding: 16px 20px; margin: 24px 0;\">\n<p style=\"color: #ffffff; font-size: 13px; line-height: 1.7; margin: 0;\"><strong style=\"color: #ffffff;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"FAQs\"><\/span><strong>FAQs<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"3_Complex_Generics_and_API_Pharma_Manufacturing_Stocks\"><\/span><strong>3 Complex Generics and API Pharma Manufacturing Stocks?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Granules India, Natco Pharma and Aurobindo Pharma are the complex generics and API pharma manufacturing stocks.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_drives_Granules_Indias_growth_in_this_theme\"><\/span><strong>What drives Granules India&#8217;s growth in this theme?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Granules India benefits from vertically integrated API and finished dosage manufacturer.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_drives_Natco_Pharmas_growth_in_this_theme\"><\/span><strong>What drives Natco Pharma&#8217;s growth in this theme?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Natco Pharma benefits from complex generics specialisation with first-to-file opportunities.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_drives_Aurobindo_Pharmas_growth_in_this_theme\"><\/span><strong>What drives Aurobindo Pharma&#8217;s growth in this theme?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Aurobindo Pharma benefits from diversified generics and API manufacturer with substantial export revenue.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_this_theme_purely_cyclical_or_structural\"><\/span><strong>Is this theme purely cyclical or structural?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The complex generics and API pharma manufacturing stocks represent a structural growth theme, though cyclicality risk remains a consideration.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_risks_apply_to_the_3_Complex_Generics_and_API_Pharma_Manufacturing_Stocks\"><\/span><strong>What risks apply to the 3 Complex Generics and API Pharma Manufacturing Stocks?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Key risks include execution risk, valuation considerations, and competitive pressure within the sector.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>3 complex generics and API pharma manufacturing stocks, Granules India, Natco Pharma and Aurobindo Pharma, capture India&#8217;s specialty pharmaceutical export demand.<\/p>\n","protected":false},"author":28,"featured_media":163797,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[24],"tags":[5161],"class_list":["post-163798","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-market","tag-complex-generics-and-api-pharma-manufacturing-stocks"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["163797"],"_edit_lock":["1784706152:28"],"_last_editor_used_jetpack":["block-editor"],"rank_math_primary_category":["24"],"rank_math_seo_score":["74"],"rank_math_title":["3 Complex Generics and API Pharma Manufacturing Stocks"],"rank_math_description":["3 complex generics and API pharma manufacturing stocks, Granules India, Natco Pharma and Aurobindo Pharma, capture India's specialty pharmaceutical export demand."],"rank_math_focus_keyword":["Complex Generics and API Pharma Manufacturing Stocks"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"],"_edit_last":["28"],"_ez-toc-disabled":[""],"_ez-toc-insert":[""],"_ez-toc-header-label":[""],"_ez-toc-alignment":["none"],"_ez-toc-heading-levels":["a:0:{}"],"_ez-toc-alttext":[""],"_ez-toc-visibility_hide_by_default":[""],"_ez-toc-hide_counter":[""],"_ez-toc-exclude":[""],"_ez-toc-position-specific":["before"],"stm_select_gm_zoom":[""],"stm_agenda":[""],"stm_host":[""],"stm_select_approved_denied":[""],"stm_multiselect_approved":[""],"stm_multiselect_denied":[""],"stm_date":[""],"stm_time":[""],"stm_timezone":[""],"stm_duration":[""],"stm_password":[""],"stm_waiting_room":[""],"stm_join_before_host":[""],"stm_host_join_start":[""],"stm_start_after_participants":[""],"stm_mute_participants":[""],"stm_enforce_login":[""],"stm_alternative_hosts":[""],"top_bar_custom_style":[""],"top_bar_bg":[""],"wc_top_bar_cart_custom_style":[""],"wc_top_bar_cart_color":[""],"wc_top_bar_cart_icon_color_hover":[""],"wc_top_bar_cart_counter_color":[""],"wc_top_bar_cart_counter_color_hover":[""],"wc_top_bar_cart_counter_bg":[""],"wc_top_bar_cart_counter_bg_hover":[""],"top_bar_wpml_switcher_custom_style":[""],"wpml_switcher_color":[""],"top_bar_wpml_switcher_bg":[""],"top_bar_wpml_switcher_bg_hover":[""],"top_bar_wpml_switcher_color_hover":[""],"top_bar_socials_custom_style":[""],"top_bar_socials_color":[""],"top_bar_socials_color_hover":[""],"top_bar_search_custom_style":[""],"top_bar_search_color":[""],"top_bar_search_icon_color_hover":[""],"top_bar_contact_info_style":[""],"top_bar_contact_info_color":[""],"top_bar_contact_info_link_color":[""],"top_bar_contact_info_link_color_hover":[""],"top_bar_contact_info_select_bg":[""],"top_bar_contact_info_select_color":[""],"top_bar_contact_info_select_drop_bg":[""],"top_bar_contact_info_select_items_bg":[""],"top_bar_contact_info_select_items_color":[""],"top_bar_contact_info_select_items_hover":[""],"header_inverse":["default"],"enable_header_transparent":["off"],"header_nav_custom_style":[""],"header_bg":[""],"header_shadow":[""],"wc_cart_custom_style":[""],"wc_cart_icon_color":[""],"wc_cart_icon_color_hover":[""],"wc_cart_counter_color":[""],"wc_cart_counter_color_hover":[""],"wc_cart_counter_bg":[""],"wc_cart_counter_bg_hover":[""],"header_wpml_switcher_custom_style":[""],"header_wpml_switcher_color":[""],"header_wpml_switcher_color_hover":[""],"header_wpml_switcher_bg":[""],"header_wpml_switcher_bg_hover":[""],"header_socials_custom_style":[""],"header_socials_color":[""],"header_socials_color_hover":[""],"header_search_custom_style":[""],"header_search_icon_color":[""],"header_search_icon_color_hover":[""],"header_contact_info_style":[""],"header_contact_info_color":[""],"header_contact_info_link_color":[""],"header_contact_info_link_color_hover":[""],"header_button_custom_style":[""],"header_button_color":[""],"header_button_color_hover":[""],"header_button_bg":[""],"header_button_bg_hover":[""],"header_nav_menu_customize":[""],"header_nav_menu_link_color":[""],"header_nav_menu_link_color_hover":[""],"header_nav_menu_link_color_active":[""],"header_nav_menu_link_arrow_color":[""],"header_nav_menu_link_arrow_color_hover":[""],"header_nav_menu_level_1_bg":[""],"header_nav_menu_level_1_link_color":[""],"header_nav_menu_level_1_link_color_hover":[""],"header_nav_menu_level_1_link_bg_hover":[""],"header_nav_menu_level_1_link_arrow_color":[""],"header_nav_menu_level_1_link_arrow_color_hover":[""],"header_nav_menu_level_2_bg":[""],"header_nav_menu_level_2_link_color":[""],"header_nav_menu_level_2_link_color_hover":[""],"header_nav_menu_level_2_link_bg_hover":[""],"header_mega_menu_bg":[""],"header_mega_menu_title_color":[""],"header_mega_menu_title_color_hover":[""],"header_mega_menu_description_color":[""],"header_mega_menu_description_link_color":[""],"header_mega_menu_description_link_color_hover":[""],"header_mega_menu_color":[""],"header_mega_menu_color_hover":[""],"header_mega_menu_border_color":[""],"header_mega_menu_icons_color":[""],"header_nav_menu_customize_end":[""],"hfe_enabled_notice":[""],"disable_title_box":["default"],"hfe_disabled":[""],"enable_transparent":["default"],"title_box_title_bg_color":[""],"title_box_bg_custom_image":["default"],"title_box_bg_image":[""],"title_box_bg_position":["default"],"metabox_title_box_bg_position_x":[""],"metabox_title_box_bg_position_y":[""],"metabox_title_box_bg_attachment":["default"],"title_box_bg_size":["default"],"metabox_title_box_bg_size_slider":[""],"title_box_bg_repeat":["default"],"disable_title":["default"],"title_box_title_color":[""],"title_box_title_line_color":[""],"disable_breadcrumbs":["default"],"metabox_title_box_breadcrumbs_color":[""],"metabox_title_box_links_color":[""],"metabox_title_box_links_color_hover":[""],"content_bg_transparent":[""],"show_popup_single":[""],"popups_single":[""],"popups_single_event":[""],"popup_single_event_open_delay":[""],"popup_single_event_showing_in":[""],"popup_single_event_date_from":[""],"popup_single_event_date_to":[""],"popup_single_event_time_from":[""],"popup_single_event_time_to":[""],"popup_single_animation":[""],"popup_single_responsive":[""],"separator_footer_copyright_border_t":[""],"name":[""],"email":[""],"phone":[""],"company":[""],"memberId":[""],"testimonial_position":[""],"testimonial_company":[""],"testimonial_bg_img":[""],"testimonial_video_url":[""],"popups_width":[""],"popups_height":[""],"popups_image_bg":[""],"popups_color_bg":[""],"popups_border_radius":[""],"popups_template":[""],"rank_math_analytic_object_id":["29254"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/07\/complex-generics-api-pharma-manufacturing-stocks-2026.png","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/163798","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/28"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=163798"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/163798\/revisions"}],"predecessor-version":[{"id":163876,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/163798\/revisions\/163876"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/163797"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=163798"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=163798"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=163798"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}